貴州百靈(002424.SZ)2019年淨利減少48.27%至2.91億元 擬10派2.2元
格隆匯4月30日丨貴州百靈(002424.SZ)發佈2019年年度報告,報告期內,公司實現營業收入28.51億元,較上年同期減少9.13%;歸屬上市公司股東淨利潤2.91億元,同比減少48.27%;基本每股收益0.21元;擬向全體股東每10股派發現金紅利2.2元(含税)。
報告期公司淨利潤增幅下滑的主要原因為:1、公司投資參股的雲植藥業和重慶海扶在本報告期實現的投資收益合計-9,034.86萬元,導致公司報告期淨利潤減少;2、報告期公司持續加強營銷網絡的建設和完善工作,大力開發基層醫療服務市場,銷售費用較上年同期增長3,723.80萬元;3、公司報告期銀行貸款增加,支付的財務費用較上年同期增加3,533.76萬元;4、管理費用受人工成本的上漲、折舊攤銷等費用的影響,較上年同期增加3,597.48萬元;5、2019年3月公司控股子公司和仁堂藥業因被收回《藥品GMP證書》,受其影響2019年和仁堂藥業實現營業收入較上年同期減少10,874.71萬元,淨利潤較上年同期減少2,026.9萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.